Literature DB >> 19270514

Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.

Dimitrios Tzachanis1, Vassiliki A Boussiotis.   

Abstract

Cellular quiescence is a state characterized by decreased cell size and metabolic activity. Quiescence acts to reduce the resources, energy and space. Quiescence might also protect cells from accumulating metabolic damage that could result in malignancy. Recent studies have shown that cell quiescence is an actively maintained rather than a default state in the absence of signals. Quiescence factors represent potential tumor suppressor genes because alterations in their expression or function contribute to progression of malignancies. There is growing evidence that quiescence is under active transcriptional control. The regulation of cell proliferation involves dozens of extracellular signals and intracellular factors of various types. In the present review we will focus on the role of Tob, a member of the APRO family members in regulating cellular quiescence and inhibition of cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270514      PMCID: PMC2908893          DOI: 10.4161/cc.8.7.8033

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  58 in total

Review 1.  Regulation of quiescence in lymphocytes.

Authors:  Isharat Yusuf; David A Fruman
Journal:  Trends Immunol       Date:  2003-07       Impact factor: 16.687

2.  Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences.

Authors:  Momoko Maekawa; Takuya Yamamoto; Eisuke Nishida
Journal:  Exp Cell Res       Date:  2004-04-15       Impact factor: 3.905

3.  Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.

Authors:  B S Fletcher; R W Lim; B C Varnum; D A Kujubu; R A Koski; H R Herschman
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

4.  Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization.

Authors:  A Bradbury; R Possenti; E M Shooter; F Tirone
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 5.  Dorsal-ventral patterning and neural induction in Xenopus embryos.

Authors:  Edward M De Robertis; Hiroki Kuroda
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

6.  Nuclear localization of Tob is important for regulation of its antiproliferative activity.

Authors:  Junko Kawamura-Tsuzuku; Toru Suzuki; Yutaka Yoshida; Tadashi Yamamoto
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

7.  Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

Authors:  Yutaka Yoshida; Takahisa Nakamura; Masato Komoda; Hitoshi Satoh; Toru Suzuki; Junko K Tsuzuku; Takashi Miyasaka; Eri H Yoshida; Hisashi Umemori; Reiko K Kunisaki; Kenzaburo Tani; Shunsuke Ishii; Shigeo Mori; Masami Suganuma; Tetsuo Noda; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

8.  Cloning and expression analysis of zebrafish tob1 gene.

Authors:  Kehui Shi; Lixia Zhang; Anming Meng
Journal:  Dev Genes Evol       Date:  2004-04-20       Impact factor: 0.900

9.  Growth stimulation leads to cellular senescence when the cell cycle is blocked.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2008-11-12       Impact factor: 4.534

10.  Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.

Authors:  Kentaro Iwanaga; Naoko Sueoka; Akemi Sato; Toru Sakuragi; Yukinori Sakao; Masaki Tominaga; Toru Suzuki; Yutaka Yoshida; Junko K-Tsuzuku; Tadashi Yamamoto; Shinichiro Hayashi; Kohei Nagasawa; Eisaburo Sueoka
Journal:  Cancer Lett       Date:  2003-12-08       Impact factor: 8.679

View more
  13 in total

Review 1.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 2.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

3.  The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.

Authors:  Reyhaneh Dehghanzad; Majid Pahlevan Kakhki; Asieh Alikhah; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Neuromolecular Med       Date:  2019-09-03       Impact factor: 3.843

Review 4.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

5.  Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).

Authors:  Yang Jiao; Ke-kang Sun; Lin Zhao; Jia-ying Xu; Li-li Wang; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

Review 6.  Quieting T cells with Slfn2.

Authors:  Maureen R Horton; Jonathan D Powell
Journal:  Nat Immunol       Date:  2010-04       Impact factor: 25.606

7.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 8.  Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.

Authors:  Hun Seok Lee; Juthika Kundu; Ryong Nam Kim; Young Kee Shin
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

9.  Transcription networks responsible for early regulation of Salmonella-induced inflammation in the jejunum of pigs.

Authors:  Marcel Hulst; Mari Smits; Stéphanie Vastenhouw; Agnes de Wit; Theo Niewold; Jan van der Meulen
Journal:  J Inflamm (Lond)       Date:  2013-04-17       Impact factor: 4.981

Review 10.  HIV restriction in quiescent CD4⁺ T cells.

Authors:  Jerome A Zack; Sohn G Kim; Dimitrios N Vatakis
Journal:  Retrovirology       Date:  2013-04-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.